96 related articles for article (PubMed ID: 16721383)
1. Inflammation and multiple myeloma: the Toll connection.
Mantovani A; Garlanda C
Leukemia; 2006 Jun; 20(6):937-8. PubMed ID: 16721383
[No Abstract] [Full Text] [Related]
2. Pathogen-associated molecular patterns are growth and survival factors for human myeloma cells through Toll-like receptors.
Jego G; Bataille R; Geffroy-Luseau A; Descamps G; Pellat-Deceunynck C
Leukemia; 2006 Jun; 20(6):1130-7. PubMed ID: 16628189
[TBL] [Abstract][Full Text] [Related]
3. Toll-like receptors mediate proliferation and survival of multiple myeloma cells.
Bohnhorst J; Rasmussen T; Moen SH; Fløttum M; Knudsen L; Børset M; Espevik T; Sundan A
Leukemia; 2006 Jun; 20(6):1138-44. PubMed ID: 16617319
[TBL] [Abstract][Full Text] [Related]
4. Expression and function of toll-like receptors in multiple myeloma patients: toll-like receptor ligands promote multiple myeloma cell growth and survival via activation of nuclear factor-kappaB.
Xu Y; Zhao Y; Huang H; Chen G; Wu X; Wang Y; Chang W; Zhu Z; Feng Y; Wu D
Br J Haematol; 2010 Sep; 150(5):543-53. PubMed ID: 20629663
[TBL] [Abstract][Full Text] [Related]
5. The role of toll-like receptor mediated signalling in the pathogenesis of multiple myeloma.
Abdi J; Engels F; Garssen J; Redegeld F
Crit Rev Oncol Hematol; 2011 Nov; 80(2):225-40. PubMed ID: 21236697
[TBL] [Abstract][Full Text] [Related]
6. Profile of Toll-like receptor expressions and induction of nitric oxide synthesis by Toll-like receptor agonists in chicken monocytes.
He H; Genovese KJ; Nisbet DJ; Kogut MH
Mol Immunol; 2006 Mar; 43(7):783-9. PubMed ID: 16098593
[TBL] [Abstract][Full Text] [Related]
7. Differential immune effects mediated by Toll-like receptors stimulation in precursor B-cell acute lymphoblastic leukaemia.
Corthals SL; Wynne K; She K; Shimizu H; Curman D; Garbutt K; Reid GS
Br J Haematol; 2006 Feb; 132(4):452-8. PubMed ID: 16412017
[TBL] [Abstract][Full Text] [Related]
8. Modulation of toll-like receptor function has therapeutic potential in autoimmune disease.
Clanchy FI; Sacre SM
Expert Opin Biol Ther; 2010 Dec; 10(12):1703-16. PubMed ID: 21039312
[TBL] [Abstract][Full Text] [Related]
9. Methylprednisolone inhibits activated CD4+ T cell survival promoted by toll-like receptor ligands.
Lu YS; Pu LY; Li XC; Wang XH
Hepatobiliary Pancreat Dis Int; 2010 Aug; 9(4):376-83. PubMed ID: 20688601
[TBL] [Abstract][Full Text] [Related]
10. In vivo administration of ligands for chicken toll-like receptors 4 and 21 induces the expression of immune system genes in the spleen.
St Paul M; Mallick AI; Haq K; Orouji S; Abdul-Careem MF; Sharif S
Vet Immunol Immunopathol; 2011 Dec; 144(3-4):228-37. PubMed ID: 22019071
[TBL] [Abstract][Full Text] [Related]
11. Various members of the Toll-like receptor family contribute to the innate immune response of human epidermal keratinocytes.
Köllisch G; Kalali BN; Voelcker V; Wallich R; Behrendt H; Ring J; Bauer S; Jakob T; Mempel M; Ollert M
Immunology; 2005 Apr; 114(4):531-41. PubMed ID: 15804290
[TBL] [Abstract][Full Text] [Related]
12. The role of toll-like receptors in chronic inflammation.
Drexler SK; Foxwell BM
Int J Biochem Cell Biol; 2010 Apr; 42(4):506-18. PubMed ID: 19837184
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of autoimmunity by toll-like receptor ligands.
Limmer A; Ganss R; Garbi N; Arnold B; Hämmerling GJ
Ann Rheum Dis; 2005 Nov; 64 Suppl 4(Suppl 4):iv15-7. PubMed ID: 16239378
[No Abstract] [Full Text] [Related]
14. Vascular cell responsiveness to Toll-like receptor ligands in carotid atheroma.
Erridge C; Burdess A; Jackson AJ; Murray C; Riggio M; Lappin D; Milligan S; Spickett CM; Webb DJ
Eur J Clin Invest; 2008 Oct; 38(10):713-20. PubMed ID: 18837796
[TBL] [Abstract][Full Text] [Related]
15. The TLR7/8 ligand resiquimod targets monocyte-derived dendritic cell differentiation via TLR8 and augments functional dendritic cell generation.
Hackstein H; Knoche A; Nockher A; Poeling J; Kubin T; Jurk M; Vollmer J; Bein G
Cell Immunol; 2011; 271(2):401-12. PubMed ID: 21889130
[TBL] [Abstract][Full Text] [Related]
16. Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways.
Sawaki J; Tsutsui H; Hayashi N; Yasuda K; Akira S; Tanizawa T; Nakanishi K
Int Immunol; 2007 Mar; 19(3):311-20. PubMed ID: 17289654
[TBL] [Abstract][Full Text] [Related]
17. Modulating responsiveness of human TLR7 and 8 to small molecule ligands with T-rich phosphorothiate oligodeoxynucleotides.
Jurk M; Kritzler A; Schulte B; Tluk S; Schetter C; Krieg AM; Vollmer J
Eur J Immunol; 2006 Jul; 36(7):1815-26. PubMed ID: 16783850
[TBL] [Abstract][Full Text] [Related]
18. The in vitro and in ovo responses of chickens to TLR9 subfamily ligands.
Jenkins KA; Lowenthal JW; Kimpton W; Bean AG
Dev Comp Immunol; 2009 May; 33(5):660-7. PubMed ID: 19100284
[TBL] [Abstract][Full Text] [Related]
19. Induction of innate immunity against herpes simplex virus type 2 infection via local delivery of Toll-like receptor ligands correlates with beta interferon production.
Gill N; Deacon PM; Lichty B; Mossman KL; Ashkar AA
J Virol; 2006 Oct; 80(20):9943-50. PubMed ID: 17005672
[TBL] [Abstract][Full Text] [Related]
20. Immunoregulation of GVHD by triggering the innate immune system with CpG.
Morecki S; Slavin S
Expert Rev Hematol; 2009 Aug; 2(4):443-53. PubMed ID: 21082948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
